BioCentury
ARTICLE | Financial News

Quantapore raises $15.6M

July 20, 2018 5:48 PM UTC

Genomic sequencing company Quantapore Inc. (Menlo Park, Calif.) raised $15.6 million on July 18 through the sale of series 3 preferred stock. Northern Light Venture Capital led the offering with participation from Tsingyuan Ventures, Sangel Venture Capital, Baidu Ventures and Cloudstone VC.

Quantapore will use the funds to deploy its nanopore DNA sequencing technology to select beta users in industry and academia. The tech is based on an optical interaction between a single DNA molecule and a nanopore for long-read DNA sequencing using hundreds of thousands of nanopores on a chip...